News | February 17, 2008

Exclusive Advanced Proton Therapy Training Facility to Open

February 18, 2008 –ProCure Treatment Centers Inc. and the University of Pennsylvania’s Roberts Proton Therapy Center have an agreement to provide advanced training programs and accredit medical professionals in proton therapy, an alternative to conventional radiation therapy that avoids many of the side effects inherent in treatment.

The agreement focuses on expanding research on the technology to be used for the delivery of proton therapy and developing new protocols using protons to treat a wider range of cancer tumors.

Protons are currently used primarily to treat about a dozen diagnoses including base-of-skull tumors, ocular melanoma, sinus tumors, pediatric cancers and prostate cancer. As more centers are developed and the capacity for patients increases, the Roberts Proton Therapy Center and ProCure have agreed to establish new clinical studies to evaluate the use of protons in areas such as proton therapy in combination with chemotherapy and the improved results obtained from increasing the dose delivered to the tumor. ProCure’s network of proton therapy centers will significantly increase the number of patients that can potentially be enrolled in studies, according to the company. The Center will provide oversight, establish data collection procedures, analyze data and work through any necessary regulatory process.

It is anticipated that within the next five years, at least 10 new proton therapy facilities will open in the U.S., including the Roberts Proton Therapy Center and several centers under development by ProCure, resulting in a need for trained staff at all levels. The Center and ProCure intend to collaborate on setting standards for proton therapy education and training, and will offer accreditation in the field. Training programs are slated to be provided at the ProCure Training and Development Center (TDC), a training center dedicated exclusively to proton therapy. The 20,000-square-foot training facility is located in Bloomington, IN. The TDC simulates a working proton therapy center and will provide training for radiation oncologists, medical physicists, dosimetrists, radiation therapists and other staff.

For more information:

Related Content

Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
FDA Clears GammaPod Stereotactic Radiotherapy System for Breast Cancer Treatment
Technology | Stereotactic Body Radiation Therapy (SBRT) | December 22, 2017
The U.S. Food and Drug Administration (FDA) has cleared the new GammaPod noninvasive stereotactic radiotherapy system...
RaySearch Launches RayCare Oncology Information System

Image courtesy of RaySearch Laboratories

Technology | Oncology Information Management Systems (OIMS) | December 22, 2017
RaySearch announced the first release of RayCare, a new oncology information system (OIS) designed to connect the...
RaySearch Releases RayStation 7 Radiotherapy Treatment Planning System
Technology | Treatment Planning | December 19, 2017
RayStation 7, the latest release of RaySearch’s radiation therapy treatment planning system, adds new functionality and...
Overlay Init